234
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Influence of polyvinylpyrrolidone quantity on the solubility, crystallinity and oral bioavailability of fenofibrate in solvent-evaporated microspheres

, , , , , , & show all
Pages 365-371 | Received 17 Jan 2016, Accepted 23 May 2016, Published online: 09 Jun 2016

References

  • Dave RH, Patel HH, Donahue E, Patel AD. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole. Drug Dev Ind Pharm, 2013;39(10):1562–72.
  • Goddeeris C, Coacci J, Vanden Mooter G. Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from smedds. Eur J Pharm Biopharm, 2007;66(2):173–81.
  • Gupta P, Kakumanu VK, Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: A molecular perspective. Pharm Res, 2004;21(10):1762–9.
  • Ha ES, Kim JS, Baek I, Hwang SJ, Kim MS. Enhancement of dissolution and bioavailability of ezetimibe by amorphous solid dispersion nanoparticles fabricated using supercritical antisolvent process. J Pharm Invest, 2015;45(7):641–9.
  • He H, Yang R, Tang X. In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm, 2010;36(6):681–7.
  • Hugo M, Kunath K, Dressman J. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: Case example fenofibrate. Drug Dev Ind Pharm, 2013;39(2):402–12.
  • Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG, Woo JS, Yong CS, Choi HG. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm, 2010;395(1-2):161–6.
  • Kim DW, Kwon MS, Yousaf AM, Balakrishnan P, Park JH, Kim DS, Lee BJ, Park YJ, Yong CS, Kim JO. Comparison of a solid SMEDDS and solid dispersion for enhanced stability and bioavailability of clopidogrel napadisilate. Carbohydr Polym, 2014;114:365–74.
  • Kim GG, Poudel BK, Marasini N, Lee DW, Hiep TT, Yang KY, Kim JO, Yong CS, Choi HG. Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems. Drug Dev Ind Pharm, 2013;39(9):1431–8.
  • Kim KS, Jin SG, Mustapha O, Yousaf AM, Kim DW, Kim YH, Kim JO, Yong CS, Woo JS, Choi HG. Novel fenofibric acid-loaded controlled release pellet bioequivalent to choline fenofibrate-loaded commercial product in beagle dogs. Int J Pharm, 2015;490:273–80.
  • Konno H, Handa T, Alonzo DE, Taylor LS. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm, 2008;70(2):493–9.
  • Lee DW, Marasini N, Poudel BK, Kim JH, Cho HJ, Moon BK, Choi HG, Yong CS, Kim JO. Application of Box–Behnken design in the preparation and optimization of fenofibrate-loaded self-microemulsifying drug delivery system (SMEDDS). J Microencapsul, 2014;31(1):31–40.
  • Lee SN, Poudel BK, Tran TH, Marasini N, Pradhan R, Im Lee Y, Lee DW, Woo JS, Choi HG, Yong CS. A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution. Arch Pharm Res, 2013;36:79–85.
  • Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS Pharm Sci Tech, 2006;7(3):E87–92.
  • Oh DH, Din FU, Kim DW, Kim JO, Yong CS, Choi HG. Flurbiprofen-loaded nanoparticles prepared with polyvinylpyrrolidone using Shirasu porous glass membranes and a spray-drying technique: Nano-sized formation and improved bioavailability. J Microencapsul, 2013;30:674–80.
  • Pradhan R, Lee DW, Choi HG, Yong CS, Kim JO. Fabrication of a uniformly sized fenofibrate microemulsion by membrane emulsification. J Microencapsul, 2013;30(1):42–8.
  • Rashid R, Kim DW, Din FU, Mustapha O, Yousaf AM, Park JH, Kim JO, Yong CS, Choi HG. Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion. Carbohydr Polym, 2015;130:26–31.
  • Tang N, Lai J, Chen Y, Lu Y, Wu W. Fenofibrate solid dispersion pellets prepared by fluid-bed coating: Physical characterization, improved dissolution and oral bioavailability in beagle dogs. J Chin Pharm Sci, 2009;18(2):156–61.
  • Tanno F, Nishiyama Y, Kokubo H, Obara S. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Drug Dev Ind Pharm, 2004;30(1):9–17.
  • Tran TH, Ramasamy T, Truong DH, Choi HG, Yong CS, Kim JO. Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement. AAPS PharmSciTech, 2014;15(6):1509–15.
  • Yang KY, Du HH, Yousaf AM, Kim DW, Shin YJ, Bae ON, Kim YI, Kim JO, Yong CS, Choi HG. Silymarin-loaded solid nanoparticles provide excellent hepatic protection: Physicochemical characterization and in vivo evaluation. Int J Nanomedicine, 2013;8:3333–43.
  • Yousaf AM, Kim DW, Choi HG, Oh E. Validation of a highly sensitive RP-HPLC method for quantification of fenofibrate in pure and pharmaceutical dosage forms. Curr Pharm Anal, 2014;10(2):97–104.
  • Yousaf AM, Kim DW, Cho KH, Kim JO, Yong CS, Choi HG. Effect of the preparation method on crystallinity, particle size, aqueous solubility and dissolution of different samples of the poorly water-soluble fenofibrate with HP-β-CD. J Incl Phenom Macrocycl Chem, 2015a;81:347–56.
  • Yousaf AM, Kim DW, Kim JO, Chang PS, Baek HH, Lim SJ, Cho KH, Yong CS, Choi HG. Characterization of physicochemical properties of spray-dried solid dispersions loaded with unmodified crystalline fenofibrate. Curr Pharm Anal, 2015b;11(2):139–44.
  • Yousaf AM, Kim DW, Oh YK, Yong CS, Kim JO, Choi HG. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: Physicochemical characterization and in vivo investigation. Int J Nanomedicine, 2015c;10:1819–30.
  • Yousaf AM, Mustapha O, Kim DW, Kim DS, Kim KS, Jin SG, Yong CS, Youn YS, Oh YK, Kim JO, Choi HG. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate. Int J Nanomedicine, 2016;11:213–21.
  • Xu W, Lee MK. Development and evaluation of lipid nanoparticles for paclitaxel delivery: A comparison between solid lipid nanoparticles and nanostructured lipid carriers. J Pharm Invest, 2015;45(7):675–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.